​

Funding Round

Series D - Fore Biotherapeutics

Series D - Fore Biotherapeutics

Investment Firm

Overview

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

Announced Date

Aug 23, 2023

Funding Type

Series D

Highlights

Location

United States, North America

Social

Investor Lead

Medicxi

Medicxi

Medicxi is a early_stage_venture and seed firm.

SR One

SR One

SR One is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

9

Investor Name
Participant InvestorSR One
Participant InvestorNovartis Venture Fund
Participant InvestorHBM Partners
Participant InvestorMedicxi
Participant InvestorWellington Management

Round Details and Background

Fore Biotherapeutics raised $75000000 on 2023-08-23 in Series D

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 22, 2016
Venture Round - Fore Biotherapeutics
1-2.5M
Dec 23, 2015
Venture Round - Fore Biotherapeutics
1-10.0M
Jul 01, 2014
Seed Round - Fore Biotherapeutics
-8.0M
Jul 01, 2013
Seed Round - Fore Biotherapeutics
-8.0M

Recent Activity

There is no recent news or activity for this profile.